Dear Steini
Chimeric Therapeutics Limited (ASX:CHM) is conducting an Entitlement Offer Shortfall Placement comprising of an equity raising of up to $5.5m via the issuance of approximately 196.7m fully paid ordinary new shares at an offer price of A$0.028 which is the same price as the entitlement offer.
Bell Potter is lead manager to the Placement. Bell Potter is currently conducting a bookbuild for the Placement which you are invited to bid into.
If you wish to participate in the offer, please send an email outlining your level of demand to Bell Potter contacts Daniel Goodman ([email protected]) and Dermott Wilson ([email protected]) by 9:30am AEDT tomorrow, 17th January 2024.
Please see the link at the button below which outlines full details of the Offer. If you have any questions, please contact Dermott or Daniel at the details above.Kind regards
Paul Hopper
Executive ChairmanJennifer Chow
Managing Director & CEO
BP Deal Sheet - Template (mcusercontent.com)
Dear SteiniChimeric Therapeutics Limited (ASX:CHM) is conducting...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
-0.001(25.0%) |
Mkt cap ! $6.045M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.3¢ | $22.28K | 6.311M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 78 | 84735861 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 86304338 | 23 |
View Market Depth
| Last trade - 14.27pm 25/07/2025 (20 minute delay) ? |
| CHM (ASX) Chart |